Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer

The tumor microenvironment (TME) is a complex ecosystem comprised of cancer cells, stromal cells, and immune cells. Analysis of the composition of TME is essential to assess the prognosis of patients with breast cancer (BC) and the efficacy of different regimes. Treg plays a crucial role in the micr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jianyu Liu, Xueying Wang, Yuhan Deng, Xin Yu, Hongbin Wang, Zhigao Li
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/3fbac8310572447aadeec835a4ae2137
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3fbac8310572447aadeec835a4ae2137
record_format dspace
spelling oai:doaj.org-article:3fbac8310572447aadeec835a4ae21372021-11-15T04:29:21ZResearch Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer2234-943X10.3389/fonc.2021.766248https://doaj.org/article/3fbac8310572447aadeec835a4ae21372021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.766248/fullhttps://doaj.org/toc/2234-943XThe tumor microenvironment (TME) is a complex ecosystem comprised of cancer cells, stromal cells, and immune cells. Analysis of the composition of TME is essential to assess the prognosis of patients with breast cancer (BC) and the efficacy of different regimes. Treg plays a crucial role in the microenvironment of breast cancer subtypes, and its function contributes to the development and progression of BC by suppressing anti-tumor immunity directly or indirectly through multiple mechanisms. In addition, conventional treatments, such as anthracycline-based neoadjuvant chemotherapy, and neo-therapies, such as immune-checkpoint blockades, have a significant impact on the absence of Tregs in BC TME, thus gaining additional anti-tumor effect to some extent. Strikingly, Treg in BC TME revealed the predicted efficacy of some therapeutic strategies. All these results suggest that we can manipulate the abundance of Treg to achieve the ultimate effect of both conventional and novel treatments. In this review, we discuss new insights into the characteristics of Treg in BC TME, the impact of different regiments on Treg, and the possibilities of Treg as a predictive marker of efficacy for certain treatments.Jianyu LiuXueying WangYuhan DengXin YuHongbin WangZhigao LiFrontiers Media S.A.articleregulatory T celltumor microenvironmentbreast cancerimmunotherapyneoadjuvant treatmentNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic regulatory T cell
tumor microenvironment
breast cancer
immunotherapy
neoadjuvant treatment
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle regulatory T cell
tumor microenvironment
breast cancer
immunotherapy
neoadjuvant treatment
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Jianyu Liu
Xueying Wang
Yuhan Deng
Xin Yu
Hongbin Wang
Zhigao Li
Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer
description The tumor microenvironment (TME) is a complex ecosystem comprised of cancer cells, stromal cells, and immune cells. Analysis of the composition of TME is essential to assess the prognosis of patients with breast cancer (BC) and the efficacy of different regimes. Treg plays a crucial role in the microenvironment of breast cancer subtypes, and its function contributes to the development and progression of BC by suppressing anti-tumor immunity directly or indirectly through multiple mechanisms. In addition, conventional treatments, such as anthracycline-based neoadjuvant chemotherapy, and neo-therapies, such as immune-checkpoint blockades, have a significant impact on the absence of Tregs in BC TME, thus gaining additional anti-tumor effect to some extent. Strikingly, Treg in BC TME revealed the predicted efficacy of some therapeutic strategies. All these results suggest that we can manipulate the abundance of Treg to achieve the ultimate effect of both conventional and novel treatments. In this review, we discuss new insights into the characteristics of Treg in BC TME, the impact of different regiments on Treg, and the possibilities of Treg as a predictive marker of efficacy for certain treatments.
format article
author Jianyu Liu
Xueying Wang
Yuhan Deng
Xin Yu
Hongbin Wang
Zhigao Li
author_facet Jianyu Liu
Xueying Wang
Yuhan Deng
Xin Yu
Hongbin Wang
Zhigao Li
author_sort Jianyu Liu
title Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer
title_short Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer
title_full Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer
title_fullStr Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer
title_full_unstemmed Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer
title_sort research progress on the role of regulatory t cell in tumor microenvironment in the treatment of breast cancer
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/3fbac8310572447aadeec835a4ae2137
work_keys_str_mv AT jianyuliu researchprogressontheroleofregulatorytcellintumormicroenvironmentinthetreatmentofbreastcancer
AT xueyingwang researchprogressontheroleofregulatorytcellintumormicroenvironmentinthetreatmentofbreastcancer
AT yuhandeng researchprogressontheroleofregulatorytcellintumormicroenvironmentinthetreatmentofbreastcancer
AT xinyu researchprogressontheroleofregulatorytcellintumormicroenvironmentinthetreatmentofbreastcancer
AT hongbinwang researchprogressontheroleofregulatorytcellintumormicroenvironmentinthetreatmentofbreastcancer
AT zhigaoli researchprogressontheroleofregulatorytcellintumormicroenvironmentinthetreatmentofbreastcancer
_version_ 1718428802775777280